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ABSTRACT

Amethod is provided for gene suppression in eukaryotes by
transformation with a recombinant construct containing a
promoter, at least one antisense andlor sense nucleotide
sequence for the gene(s) to be suppressed, wherein the
nucleus-to-cytoplasm transport of the transcription products
of the construct is inhibited. In one embodiment, nucleusto-cytoplasm transport is inhibited by the absence of a
normal 3' UTR. The construct can optionally include at least
one self-cleaving ribozyme. The construct can also optionally include sense andlor antisense sequences to multiple
genes that are to be simultaneously down-regulated using a
single promoter. Also disclosed are vectors, plants, animals,
seeds, gametes, and embryos containing the recombinant
constructs.
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DOWN-REGULATION OF SINGLE GENES AND
SIMULTANEOUS DOWN-REGULATION OF
MULTIPLE GENES BY NUCLEAR
LOCALIZATION OF RNA TRANSCRIPTS
CROSS-REFERENCE TO RELATED
APPLICATIONS

[0001] This application claims the benefit of U.S. Provisional patent application Ser. No. 601222,510, filed Aug. 2,
2000, which is herein incorporated by reference in its
entirety for all purposes.
BACKGROUND

[0002] The present invention is directed to a method for
suppressing the expression of a gene or genes using nuclear
localized RNA transcripts. Also, this invention is directed to
the use of a single promoter to down-regulate more than one
gene simultaneously.
[0003] There are currently at least four known methods for
gene down-regulation or suppression in plants. One strategy
is targeted gene disruption(s) or gene knockout(s) that relies
on homologous recombination. "Knockout" refers to a DNA
sequence that has been altered via any known means, for
example, deletion, insertion, point mutation or rearrangement, so as to eliminate the function of the gene product.
One strategy that generates a gene knockout in plants
employs chimeric RNNDNA oligonucleotides to generate
site-specific mutations including gene knockouts (Beetham
et al., (1999) Proc. Natl. Acad. Sci. USA, 963774). This
technology requires specialized oligonucleotides and biolistic delivery that produces large numbers of undesirable
off-type transgenics. It is also not clear whether the oligonucleotide-directed mutations are restricted to target genes.
[0004] Another strategy for gene down-regulation is
expression of antisense transcripts, where the gene of interest has an antisense orientation between a promoter and an
appropriate 3' terminal sequence for nuclear export. As is
well known, a cell manufactures protein by transcribing the
DNA of the gene for that protein to produce RNA, which is
then processed (e.g. by the removal of introns) into messenger RNA (mRNA) and finally translated by ribosomes
into protein. This process may be inhibited by the presence
in the cell of "antisense RNA". Therefore, as used herein, the
term "antisense RNA" means an RNA seauence which is
complementary to a sequence of bases in a RNA: complementary in the sense that each base (or a majority of bases)
in the antisense sequence (read in the 3' to 5' sense) is
capable of pairing with the corresponding base (G with C, A
with U) in the mRNA sequence read in the 5' to 3' sense. It
is believed that this inhibition takes place by formation of a
complex between the two complementary strands of RNA,
preventing the production of protein. How this works is
uncertain: the complex may interfere with further transcription, processing, transport or translation, or lead to degradation of the mRNA, or have more than one of these effects.
Such antisense RNA may be produced in the cell by transformation with an appropriate DNA construct arranged to
transcribe part of the antisense or anticoding strand (as
opposed to the template strand) of the relevant gene (or of
a DNA sequence showing substantial homology therewith).
[0005] The use of this technology to down-regulate the
expression of specific plant genes has been described, for

example in European Patent Publication No 271988. Reduction of gene expression by the use of antisense RNA has led
to a change in the phenotype of the plant: either at the level
of gross visible phenotypic difference e.g. lack of lycopene
synthesis in the fruit of tomato leading to the production of
yellow rather than red fruit, or at a more subtle biochemical
level e.g. change in the amount of polygalacturonase and
reduction in depolymerisation of pectins during tomato fruit
ripening (U.S. Pat. Nos. 5,073,676, 5,107,065, 5,569,831;
Smith et al, (1988) Nature, 334,724-726; Smith et al, (1990)
Plant Mol. Biol. 14, 369-380). Thus, antisense RNA is one
method used in achieving down-regulation of gene expression in vlants. However. antisense down-remlation
is often
u
leaky since there is frequently a reduction of the gene
product but not always a complete shut-down of the gene
product.

[0006] In some instances, antisense constructs have been
combined with ribozymes. Ribozymes are catalytic RNA
molecules that can promote specific biochemical reactions
without the need for auxiliary proteins. U.S. Pat. No. 5,814,
500 discloses a construct containing an antisense sequence
flanked on both ends by a U1 snRNA stem loop structure.
The stem loop structure is believed to give the antisense
construct enhanced stability by being resistant to nuclease
activity and by being enriched in the nucleus. In one
embodiment, the construct contains a ribozyme sequence
which cleaves a target RNA and is located between stem
loop structures which were placed on each end of the
construct. The patent teaches the use of this construct in
animal cells. Likewise. U.S. Pat. No. 5.908.779
discloses
,
,
mammalian cells containing a promoter, an antisense
sequence and a cis-ribozyme. The use of antisense construct
harboring cis-acting ribozymes has not been successfully
applied to plants.
[0007] A third strategy for gene down-regulation is cosuppression. Co-suppression can occur when the gene of
interest is expressed in the sense orientation between a
promoter and an appropriate 3' terminal sequence for nuclear
export. Co-suppression results in reduced expression of the
transgene as well as the endogenous gene. Insertion of a
related gene or promoter into a plant can induce rapid
turnover of homologous endogenous transcripts, a process
believed to have many similarities to the mechanism responsible for antisense RNA inhibition. The effect depends on
sequence identity between the transgene and the endogenous
gene. Some cases of co-suppression resemble RNA interference (the experimental silencing of genes by the introduction of double-stranded RNA), as RNAseems to be both
an important initiator and a target in these processes. Various
regulatory sequences of DNA can be altered (promoters,
polyadenylation signals, post-transcriptional processing
sites) or used to alter the expression levels (enhancers and
silencers) of a specific mRNA.
[0008] The fourth strategy for gene down-regulation or
suppression is RNA interference. Introduction of doublestranded RNA induces potent and specific gene silencing, a
vhenomenon called RNA interference or RNAi. In RNAi.
inverted repeats, which presumably form strong secondary
structure in vivo, cause genetic down-regulation. (Sharp et
al. (2000) Science 287:2431-2433). The mechanism of how
RNAi results in the loss of the targeted homologous mRNA
is still not well understood. The RNAi stratenv
is effective
u,
for gene down-regulation in plants, and is distinct from the
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method using expression of antisense transcripts because the
base pairing in RNAi occurs intramolecularly.

wherein nucleus-to-cytoplasm transport of transcription
products of said at least one nucleotide sequence is inhibited.

[0009] Importantly, current models generally indicate that
the mechanisms for the above down-regulation strategies
originate in the cytoplasm of the cell. (Marx, J. (2000)
Science 288:1370-1372; Wolfe et al., (1999) Science
286:481-486; Waterhouse et al. (1998) PNAS 95:1395913964). Cytoplasmic localization of transcripts presumably
causes dilution of the transcripts as opposed to nuclear
localization. Thus. there remains a need in the art for
methods useful in the suppression and down-regulation of
genes which uses a nuclear localization strategy of RNA
transcripts in order to increase the efficacy of gene downregulation.

[0017] Still another aspect provides, a eukaryotic cell
whose genome includes a recombinant construct comprising
a promoter functional in the eukaryotic cell operatively
linked to at least one sense nucleotide sequence of at least
one gene to be suppressed, wherein nucleus-to-cytoplasm
transport of transcription products of the construct is inhibited.

SUMMARY
[0010] One aspect of the present invention, therefore,
provides a method by which expression of genes can be
suppressed (down regulated). Described herein are constructs and methods which allow the nuclear localization of
RNA. The presence of high concentrations of either sense or
antisense RNA within the nucleus results in the suppression
of the gene or genes of interest.
[0011] Another aspect provides a method for suppressing
gene expression in a eukaryotic cell comprising transforming the cell with a recombinant construct comprising, a
promoter functional in the cell operatively linked to a sense
nucleotide sequence of a gene to be suppressed, wherein
nucleus-to-cytoplasm transport of transcription products of
the construct is inhibited. In one embodiment, the construct
can contain sequences for the suppression of multiple genes.
[0012] Afurther aspect provides a method for suppressing
gene expression in a eukaryotic cell comprising transforming the cell with a recombinant construct comprising, a
promoter functional in the cell operatively linked to a
plurality of antisense nucleotide sequences of a gene or
genes to be suppressed, wherein nucleus-to-cytoplasm transport of transcription products of the construct is inhibited.
[0013] Still another aspect provides a method for suppressing expression of a gene in a plant cell comprising,
transforming the plant cell with a recombinant construct
comprising, a promoter functional in said plant; and an
antisense nucleotide sequence for the gene to be suppressed,
wherein nucleus-to-cytoplasm transport of transcription
products of the construct is inhibited.
[0014] Yet another aspect provides a recombinant vector
comprising a promoter functional in a eukaryotic cell operatively linked to at least one sense nucleotide sequence of at
least one gene to be suppressed, wherein nucleus-to-cytoplasm transport of transcription products of said at least one
nucleotide sequence is inhibited.
[0015] An additional aspect provides a recombinant vector
comprising a promoter functional in a eukaryotic cell operatively linked to a plurality of antisense nucleotide sequences
of at least one gene to be suppressed, wherein nucleus-tocytoplasm transport of transcription products of said at least
one nucleotide sequence is inhibited.
[0016] Another aspect provides a recombinant vector
comprising a promoter functional in a plant; and at least one
antisense sequence for at least one gene to be suppressed;

[0018] An additional aspect provides, a eukaryotic cell
whose genome includes a recombinant construct comprising
a promoter functional in the eukaryotic cell operatively
linked to a plurality of antisense nucleotide sequences of at
least one gene to be suppressed, wherein nucleus-to-cytoplasm transport of transcription products of the construct is
inhibited.
[0019] A further aspect provides, a plant cell whose
genome includes a recombinant construct comprising, a
promoter functional in said plant cell operatively linked to at
least one antisense sequence for at least one gene to be
suppressed; wherein nucleus-to-cytoplasm transport of transcription products of the construct is inhibited.
[0020] In still further aspects, any of the aforementioned
constructs which contain more than one sequence can comprising a combination of sense and antisense sequences.
[0021] Additional aspects include, plants and animals
comprising any of the aforementioned cells or constructs;
and seed, gametes, embryos, progeny and uniform populations obtained from such plants or animals.
[0022] In any of the aforementioned aspects, the inhibition
of nucleus-to-cytoplasm transport can be due to the absence
of appropriate 3' terminal sequences (3' UTR), which are
typically necessary for nucleus-to-cytoplasm transport of
transcription products, or the presence of 3' terminal
sequences that prevent or avoid nuclear-to-cytoplasm transport of transcription products.
[0023] In additional aspects, any of the aforementioned
constructs can include at least one self cleaving ribozyme.
[0024] In still further aspects, any of the aforementioned
promoters can be constitutive, inducible, tissue specific,
developmentally regulated, or a suitable combination such
as an inducible, tissue specific promoter.
BRIEF DESCRIPTION OF THE DRAWINGS
[0025] These and other features, aspects, and advantages
of the present invention will become better understood with
regard to the following description, appended claims and
accompanying figures where:
[0026] FIG. 1 shows the arrangement of pertinent DNA
sequences for the binary vectors pPTN102, pPTN110,
pPTN111, pPTN112 and pPTN113. The sizes of the different
regions are not to scale. Abbreviations used are as follows:
LB=left border, hpt=hygromycin phosphotransferase ORF,
Pnos=nopaline synthase promoter, E35S=cauliflower
mosaic virus 35s enhancer, TEV=tobacco etch virus translational leader, T35S=cauliflower mosaic virus 3 5 s 3' terminal sequence, RB=right border, nptII=neomycin phosphotranferase ORF, P35S=cauliflower mosaic virus promoter,
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RZ=ribozyme, GUS sense=GUS ORF in sense orientation,
anti GUS=GUS ORF in antisense orientation.

[0027] FIG. 2 shows the arrangement of pertinent DNA
sequences for the binary vectors pPTN166, pPTN167,
pPTN170 and pPTN326 that a single gene knockout constructs for soybean. The sizes of different regions are not to
scale. Abbreviations are the same as for FIG. 1 with the
following additions: bar=glufosinate resistance gene, FAD21=FAD2-1 gene in sense orientation, anti-FAD2-l=FAD2-1
gene in antisense orientation, PhP=Phaseolin promoter.

[0038] 35S=CaMV35S=cauliflower mosaic virus 3 5 s
[0039] FAD2-1=An omega-6-desaturase that catalyzes
desaturation at the omega 6 carbon (sixth carbon from
the end).
[0040] ddH,O=deionized, distilled water
[0041] MOPS=2-(N-Morpho1ino)-2-hydroxypropanesulfonic acid
[0042] EDTA=ethylenediaminetetraacetic acid

[0028] FIG. 3 shows the arrangement of pertinent DNA
sequences for the binary vectors pPTN300 and pPTN303
that are dual gene knockout constructs for soybean. The
sizes of different regions are not to scale. Abbreviations are
the same as for FIGS. 1 and 2 with the following additions:
B-C-=fl-conglycinin promoter, FatB=FatB gene in sense
orientation.

[0043] SDS=sodium dodecyl sulfate

[0029] FIG. 4 shows a photograph of nuclei-enriched
fraction from tobacco. The color picture on the left was
stained with propidium iodide. The phase contrast picture on
the right is of the same region.

[0047]

[0030] FIG. 5 shows a Northern hybridization for transgenic tobacco harboring pPTN102 (total RNA, lane 1 and
nuclei RNA, lane 2), pPTNllO (total RNA, lane 3 and nuclei
RNA, lane 4), pPTNlll (total RNA, lane 5 and nuclei RNA,
lane 6), pPTN112 (total RNA, lane 7 and nuclei RNA, lane
8), and pPTN113 (total RNA, lane 9 and nuclei RNA, lane
10). The upper portion was probed with the TEV-GUS
sequence from pPTN102 and the lower portion was probed
with rDNA.

[0050] FITC=fluorescein isothiocyanate

[0031] FIG. 6 shows photographs of in situ hybridizations. The pictures in the column on the left were taken using
the red channel to show nuclei. The pictures in the center
column were taken using the green channel to show probe
hybridizations. The pictures in the column on the right are
the red and green channels combined. The rows of pictures
are arranged to show tobacco sections harboring pPTNlll
or pPTN112 probed with either the GUS sense probe or the
GUS antisense probe.

[0053] 3' UTR=3' untranslated region or sequence of a
gene or the transcription product of that gene.

DETAILED DESCRIPTION

[0032] The following detailed description is provided to
aid those skilled in the art in practicing the present invention.
Even so, this detailed description should not be construed to
unduly limit the present invention as modifications and
variations in the embodiments discussed herein can be made
by those of ordinary skill in the art without departing from
the spirit or scope of the present inventive discovery.
[0033] All publications, patents, patent applications and
other references cited in this application are herein incorporated by reference in their entirety as if each individual
publication, patent, patent application or other reference
were specifically and individually indicated to be incorporated by reference.
[0034] The following abbreviations and definitions are
used herein.
[0036] ORF=open reading frame
[0037] TEV=tobacco etch virus

[0044] SSC=standard saline citrate (20x SSC=3 M
NaC1, 0.3 M citrate.2H20, pH=7)
[0045] TE=10 mM Tris, 1 mM EDTA

l x TBS=20 mM Tris, 0.5M NaC1, pH=7.5

[0048] TTBS=0.05% Tween 20, l x TBS
[0049] BSA=bovine serum albumin

[0051] LB=Luria-Bertani medium=lO g bacto-tryptone,
5 g bacto-yeast extract, 10 g NaCl in one liter water,
pH=7.
[0052] T-DNA=that part of the Agrobacterium Ti plasmid that is incorporated into the genome of infected
plant cells.

[0054] The term "expression" in the context of a gene or
polynucleotide involves the transcription of the gene or
polynucleotide into RNA. The term can also, but not necessarily, involve the subsequent translation of the RNA into
polypeptide chains and their assembly into proteins.
[0055] As used herein, "expression vector" means a vector
that promotes transcription of a gene or polynucleotide.
When placed in a suitable host cell, transcripts from an
expression vector can result in synthesis of a protein or
polypeptide.
[0056] As used herein, "polynucleotide" and "oligonucleotide" are used interchangeably and mean a polymer of at
least 2 nucleotides joined together by phosphodiester bonds
and may consist of either ribonucleotides or deoxyribonucleotides.
[0057] As used herein, "sequence" means the linear order
in which monomers occur in a polymer, for example, the
order of amino acids in a polypeptide or the order of
nucleotides in a polynucleotide.
[0058] As used herein, "peptide" and "protein" are used
interchangeably and mean a compound that consists of two
or more amino acids that are linked by means of peptide
bonds.
[0059] As used herein, "organelle" means any discrete
structure in a cell that is adapted andlor specialized for the
performance of one or more vital functions and can include
plastids and mitochondria.
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[0060] As used herein, "recombinant construct" is defined
either by its method of production or its structure. In
reference to its method of production, e.g., a product made
by a process, the process is use of recombinant nucleic acid
techniques, e.g., involving human intervention in the nucleotide sequence, typically selection or production. Alternatively, it can be a sequence comprising fusion of two nucleic
acid sequences which are not naturally contiguous to each
other, but is meant to exclude products of nature, e.g.,
naturally occurring mutants.
[0061] The present invention is directed to the suppression
of gene expression by use of a DNA construct comprising a
promoter, and a sense or antisense sequence for the gene or
genes to be suppressed wherein the normal nucleus-tocytoplasm transport of the RNA transcript of the construct is
inhibited. In one embodiment. transvort is inhibited due to
the absence of the normal 3' terminal sequence. As used
herein, a "normal" 3' terminal sequence (3' UTR) is a
sequence found at the 3' end of a gene that is involved in
nuclear-to-cytoplasm transport of transcription products of
the gene. The absence of a "normal" 3' UTR from a gene or
the transcription product of that gene, or the replacement of
a "normal" 3' UTR with an appropriate alternative sequence
will prevent or inhibit nucleus to cytoplasm transport of the
transcription product (Eckner et al., EMBO J., 10:35133522; Huang and Carmichael (1996) Molec. Cell. Biol.,
16:1534-1542). In another embodiment, the construct also
includes a self-cleaving ribozyme. It should be recognized
that the suppression of gene expression need not be complete. Rather, the rate of translation of the protein encoded
by the gene to be suppressed need only be decreased when
compared to the rate of expression observed in the absence
of the construct. In one embodiment, the rate of expression
is decreased by at least 10%. In another embodiment, the
rate of expression is decreased by at least 50% and in yet
another embodiment, the rate of expression is decreased at
least 75%. In still another embodiment, the rate of expression is decreased at least 95%.
[0062] The present invention is useful for altering physiological processes within a cell or tissue. For example, and
without limitation, the present invention can be used to alter
the patterns of enzymes produced which in turn can alter
biochemical pathways resulting in the altered accumulation
of the end products of such pathways. One non-limiting
example is the type of fatty acids produced by the plant.
Examples of other physiological processes which may be
altered using the present invention include, flowering, and
the ripening, spoilage of fruit and the fatty acid composition
of meat and milk.
[0063] The present invention also has therapeutic uses
such as the suppression of undesirable genes. These genes
may be native genes or can be exogenous genes such as
those due to viral or retroviral infection. Therefore. the
present invention can be used to resist or treat such infections.
[0064] Any promoter that functions in the chosen host
may be used in practicing the present invention. The promoter may be homologous or heterologous to the sequence
controlled. Promoters useful in the present invention include
those that confer appropriate cellular and temporal specificity of expression. Such promoters include those that are
constitutive or inducible, environmentally-regulated, devel-

opmentally-regulated, cell-specific, or tissue-specific. In
plants, often-used constitutive promoters include the CaMV
35s promoter (Ode11 et al. (1985) Nature 313: 810), the
enhanced CaMV 3 5 s promoter, the Figwort Mosaic Virus
(FMV) promoter (Richins et al. (1987) NAR 20: 8451), the
mannopine synthase (mas) promoter, the nopaline synthase
(nos) promoter, and the octopine synthase (ocs) promoter.

[0065] Useful inducible promoters in plants include heatshock promoters (Ou-Lee et al. (1986) Pvoc. Natl. Acad. Sci.
USA 83: 6815; Ainley et al. (1990) PlantMol. Biol. 14: 949),
a nitrate-inducible promoter derived from the spinach nitrite
reductase gene (Back et al. (1991) Plant Mol. Biol. 17:9),
hormone-inducible promoters (Yamaguchi-Shinozaki et al.
(1990) Plant Mol. Biol. 15: 905; Kares et al. (1990) Plant
Mol. Biol. 15: 905), and light-inducible promoters associated with the small subunit of RuBP carboxylase and LHCP
gene families (Kuhlemeier et al. (1989) Plant Cell 1: 471;
Feinbaum et al. (1991) Mol. Gen. Genet. 226: 449; Weisshaar et al. (1991) EMBO J. 10: 1777; Lam and Chua (1990)
Science 248: 471; Castresana et al. (1988) EMBO J. 7: 1929;
Schulze-Lefert et al. (1989) EMBO J. 8: 651).
[0066] Examples of useful tissue-specific, developmentally-regulated promoters in plants include fruit-specific
promoters such as the E4 promoter (Cordes et al. (1989)
Plant Cell 1:1025), the E8 promoter (Deikman et al. (1988)
EMBO J. 7: 3315), the kiwi fruit actinidin promoter (Lin et
al. (1993) PNAS 90: 5939), the 2 A l l promoter (Houck et al.,
U.S. Pat. No. 4,943,674), and the tomato pZ130 promoter
(U.S. Pat. Nos. 5,175,095 and 5,530,185); the 0-conglycinin
7 s promoter (Doyle et al. (1986) J. Biol. Chem. 261: 9228;
Slighton and Beachy (1987) Planta 172: 356), and seedspecific promoters (Knutzon et al. (1992) Pvoc. Natl. Acad.
Sci. USA 89: 2624; Bustos et al. (1991) EMBO J. 10: 1469;
Lam and Chua (1991) J. Biol. Chem. 266: 17131; Stayton et
al. (1991) Aust. J. Plant. Physiol. 18: 507). Fruit-specific
gene regulation is discussed in U.S. Pat. No. 5,753,475.
Other useful seed-specific promoters include, but are not
limited to, the napin, phaseolin, zein, soybean trypsin inhibitor, 7S, ADR12, ACP, stearoyl-ACP desaturase, oleosin,
Lasquerella hydroxylase, and barley aldose reductase promoters (Bartels (1995) Plant J. 7: 809-822), the EA9 promoter (U.S. Pat. No. 5,420,034), and the Bce4 promoter
(U.S. Pat. No. 5,530,194). Useful embryo-specific promoters include the corn globulin 1 and oleosin promoters.
Useful endosperm-specific promoters include the rice glutelin-1 promoter, the promoters for the low-pI a-amylase
gene (Amy32b) (Rogers et al. (1984) J. Biol. Chem. 259:
12234), the high-pI a-amylase gene (Amy 64) (Khurseed et
al. (1988) J. Biol. Chem. 263: 18953), and the promoter for
a barley thiol protease gene ("Aleurain") (Whittier et al.
(1987) Nucleic Acids Res. 15: 2515).
[0067] Other promoters known to control the expression
of genes in prokaryotic or eukaryotic cells can be used and
are known to those skilled in the art. For example, the casein
promoter can be used to direct expression of foreign protein(~)in the milk. Promoter hybrids can also be constructed
to enhance transcriptional activity (Hoffman, U.S. Pat. No.
5,106,739), or to combine desired transcriptional activity
and tissue specificity.
[0068] One embodiment of the present invention involves
the use of antisense sequences. Antisense sequences can be
produced by reversing the orientation of the transcribed
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region of a gene or polynucleotide sequence whose suppression is desired. When operatively coupled to a suitable
transcriptional promoter such as those discussed above, a
transcript of the antisense DNA strand is produced. The
production and use of antisense DNA is well known in the
art and can be found, for example, in Green et al., (1986)
Annu. Rev. Biochem. 55:569. The transcript of the antisense
DNA is antisense RNA. Without being bound by theory, it
is believed that an individual antisense RNA molecule may
hybridize with a complementary "sense" mRNAmolecule to
form an RNA-RNA duplex. Such a duplex may prevent the
sense mRNA molecule from being translated, effectively
suppressing production of the ultimate gene product, a
protein. The presence of RNA-RNA duplexes may also
initiate a sequence-specific RNA degradation pathway with
the antisense molecules andlor the RNA-RNA duplexes
playing a role in initiating the degradation pathway, and both
sense and antisense molecules serving as specific targets for
degradation. Formation of RNA-RNA duplexes is believed
to be most efficient when the sense and antisense RNAs are
retained in close proximity to each other. One advantage of
the present invention is that the antisense RNA is not
transported out of the nucleus into the cytoplasm. This
maintains a relatively high concentration of antisense RNA
within the nucleus and thereby may increase the likelihood
that RNA-RNA duplexes will form before the sense mRNA
is transported to the cytoplasm where translation can occur.
It will be apparent to one of ordinary skill in the art, that the
antisense transcript need not encompass the entire gene or
polynucleotide sequence, but may be a fragment which
hybridizes to only a portion of the sense RNA. The antisense
transcript should be of sufficient length to allow specificity
in binding to the target (sense) transcript. In general, the
antisense transcript should be at least 10 bases long,
although the presence of rare sequences may allow the use
of shorter antisense transcripts.
[0069] As with antisense sequences, sense sequences used
in the practice of the present invention need not encompass
the entire gene. Rather, the sense sequences used can include
only a portion of the gene. In one embodiment, the sense
sequences include the coding portion of the gene. In another
embodiment, the sequences are at least about 10 bases long.
[0070] An additional embodiment involves the use of a
self-cleaving ribozyme, preferably located downstream to
the sense or antisense sequence of the construct. Ribozymes
are catalytic RNA molecules that can promote specific
biochemical reactions without the need for auxiliary proteins. Reactions catalyzed by ribozymes can be either
intramolecular or intermolecular. Examples of intramolecular reactions are self-splicing or self-cleaving reactions
while intermolecular reactions involve other RNA molecules as substrates and more closely approximate true
enzymatic reactions where the enzyme is unchanged after
each reaction. In the present invention, a self-cleaving
ribozyme is used. In one embodiment, the self-cleaving
ribozyme is the RZ ribozyme described in U.S. Pat. No.
5,908,779 and Liu and Carmichael (1994) Molec. Biotechnol. 2:107. In one embodiment, the ribozyme replaces the 3'
terminal sequence normally found in RNA to be transported
to the cytoplasm for translation. In addition, the ribozyme
acts to cleave itself from the transcript produced creating a
free transcript and further insuring that the transcript
remains within the nucleus.

[0071] In addition, the present invention can also employ
constructs that result in RNA with secondary structure
(RNAi). An example of such secondary structure that
induces RNAi would be encompassed in a construct that
expresses a single transcript that has both sense and complementary antisense sequences from the target gene or genes.
[0072] optionally, the construct may also include an
enhancer. Enhancers are DNA sequences found in eukaryotes that increase the rate of transcription of genes present on
the same molecule, but which do not have promoter activity.
An enhancer can be placed upstream or downstream of a
promoter or in forward or reverse orientation without loss of
activity.
[0073] The constructs of the present invention are produced using methods well known to those of ordinary skill
in the art which can be found, for example, in standard texts
such as Sambrook et al., Molecular Cloning, 2nd ed., Cold
Spring Harbor Laboratory Press, 1989 and Ausubel, et al.,
Short Protocols in Molecular Biology, 3rd ed., Wiley &
Sons, 1995. In general, recombinant constructs are produced
by a series of restriction enzyme digestions and ligation
reactions which result in the desired sequences being incorporated into a plasmid. If suitable restriction sites are not
available, then synthetic oligonucleotide adapters or linkers
can be used as is known to those skilled in the art and
described in the references cited above. The DNAconstructs
are assembled such that the promoter, sense DNA andlor
antisense DNA and ribozyme are operatively linked. A
nucleic acid sequence is operably linked when it is placed
into a functional relationship with another nucleic acid
sequence. For example, a promoter is operably linked to a
sequence if it affects the transcription of the sequence; or a
ribosome binding site is operably linked to a coding
sequence if it is positioned so as to facilitate translation.
[0074] It will be apparent to those of ordinary skill in the
art, that the precise restriction enzymes, linkers andlor
adaptors required as well as the precise reaction conditions
will vary with the sequences and cloning vectors used. The
assembly of DNA constructs, however, is routine in the art
and can be readily accomplished by the skilled technician
without undue experimentation. Non-limiting illustrations
of the assembly of DNA constructs useful in the present
invention can be found in the examples that follow.
[0075] The DNA construct can then be placed into a
suitable vector to transform a host cell. The vector can be
either a cloning vector or an expression vector. A cloning
vector is a self-replicating DNA molecule that serves to
transfer a DNA segment into a host cell. The three most
common types of cloning vectors are bacterial plasmids,
phages, and other viruses. An expression vector is a cloning
vector designed so that a coding sequence inserted at a
particular site will be transcribed into mRNA. Both cloning
and expression vectors contain nucleotide sequences that
allow the vectors to replicate in one or more suitable host
cells. In cloning vectors, this sequence is generally one that
enables the vector to replicate independently of the host cell
chromosomes, and also includes either origins of replication
or autonomously replicating sequences. Various bacterial
and viral origins of replication are well known to those
skilled in the art and include, but are not limited to, the
pBR322 plasmid origin, the 2p plasmid origin, and the
SV40, polyoma, adenovirus, VSV and BPV viral origins.
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Ausubel et al., ed., Short Pvotocols in Moleculav Biology,
3rd ed., Wiley & Sons, 1995.

[0076] Vectors can and usually do contain a selection gene
or selection marker. Typically, this gene encodes a protein
necessary for the survival or growth of the host cell transformed with the vector. Examples of suitable selection
markers include dihydrofolate reductase (DHFR) or neomycin resistance for eukaryotic cells and tetracycline or ampicillin resistance for E. coli. Selection genes in plants include
genes that confer resistance to bleomycin, gentamycin,
glyphosate, hygromycin, kanamycin, methotrexate, phleomycin, phosphinotricin, spectinomycin, streptomycin, sulfonamide and sulfonylureas. Maliga et al., Methods in Plant
Moleculav Biology, Cold Spring Harbor Laboratory Press,
1995, p. 39.
[0077] In addition, vectors can also contain marker
sequences. Suitable markers include, but are not limited to,
alkaline phosphatase (AP), myc, hemagglutinin (HA),
0-glucuronidase (GUS), luciferase, and green fluorescent
protein (GFP).
[0078] A further embodiment of the present invention
relates to transformed host cells containing constructs of the
present invention. The host cell can be a higher eukaryotic
cell, such as a plant or animal cell, or a lower eukaryotic cell
such as a yeast cell. Introduction of the construct into the
host cell can be accomplished by a variety of methods
including calcium phosphate transfection, DEAE-dextran
mediated transfection, Polybrene, protoplast fusion, liposomes, direct microinjection into the nuclei, scrape loading,
and electroporation. In plants, a variety of different methods
can be employed to introduce transformation1expression
vectors into plant protoplasts, cells, callus tissue, leaf discs,
meristems, etc., to generate transgenic plants. These methods include, for example, Agrobacterium-mediated transformation, particle gun delivery, microinjection, electroporation,
polyethylene
glycol-mediated
protoplast
transformation, liposome-mediated transformation, etc.
(reviewed in Potrykus (1991) Annu. Rev. Plant Physiol.
PlantMol. Biol. 42: 205). In one embodiment, plant cells are
transformed using Agrobacterium-mediated transformation
and a binary vector system in which the vectors were
introduced into the Agrobacterium by triparental matings
(see, Maliga et al., Methods in Plant Moleculav Biology,
Cold Spring Harbor Laboratory Press, 1995, Sec. 4).
[0079] Transgenic animals can be produced by the injection of the aolvnucleotides of the aresent invention into the
pronucleus of a fertilized oocyte, by transplantation of cells,
preferably undifferentiated cells, into a developing embryo
to produce a chimeric embryo, transplantation of a nucleus
from a recombinant cell into an enucleated embryo or
activated oocyst, or by any other method capable of producing a transgenic animal. Methods for the production of
transgenic animals can be found in a number of references
including, for example, U.S. Pat. No. 4,873,191; Rudolph
(1999) Trends Biotechnol., 17:367-374; Dalrymple et al.
(1998) Biotechnol. Genet. Eng. Rev., 15:33-49; Colman
(1998) Biochem. Soc. Symp., 63:141-147; Wilmut et al.,
(1997) Natuve 385:810-813; Wilmut et al. (1998) Repvod.
Fevtil. Dev., 10:639-643; Perry et al. (1993) Tvamgenic Res.,
2:125-133; Hogan et al., Manipulating the Mouse Embryo,
2nd ed., Cold Spring Harbor Laboratory Press, 1994; and
references cited therein. Of course, gametes, seeds,
L

,

embryos, progeny and hybrids of plants or animals containing constructs of the present invention produced by traditional breeding methods are also included within the scope
of the present invention.

[0080] In general, transgenic plants can be produced by
transforming plant cells with a DNA construct as described
above via any of the foregoing methods; selecting plant cells
that have been transformed on a selective medium; regenerating plant cells that have been transformed to produce
differentiated plants; and selecting a transformed plant that
expresses the construct at a level sufficient to result in gene
suppression.
[0081] Specific methods for transforming a wide variety of
dicots and obtaining transgenic plants are well documented
in the literature (Gasser and Fraley (1989) Science 244:
1293; Fisk and Dandekar (1993) Scientia Hovticultuvae 55:
5; Christou (1994) Agro Food Industry Hi Tech, p. 17; and
the references cited therein).
[0082] Examples of successful transformation and plant
regeneration in monocots are as follows: asparagus (Aspavagus officinalis; Bytebier et al. (1987) Pvoc. Natl. Acad. Sci.
USA 84: 5345); barley (Hovdeum vulgavae; Wan and
Lemaux (1994) Plant Physiol. 104: 37); maize (Zea mays;
Rhodes et al. (1988) Science 240: 204; Gordon-Kamm et al.
(1990) Plant Cell 2: 603; Fromm et al. (1990) BioITechnology 8: 833; Koziel et al. (1993) BioITechnology 11: 194);
oats (Avena sativa; Somers et al. (1992) BioITechnology 10:
1589); orchardgrass (Dactylis glomevata; Horn et al. (1988)
Plant Cell Rep. 7: 469); rice (Ovyza sativa, including indica
and japonica varieties; Toriyama et al. (1988) BioITechnology 6: 10; Zhang et al. (1988) Plant Cell Rep. 7: 379; Luo
and Wu (1988) Plant Mol. Biol. Rep. 6: 165; Zhang and Wu
(1988) Theor: Appl. Genet. 76: 835; Christou et al. (1991)
BioITechnology 9: 957); rye (Secale ceveale; De la Pena et
al. (1987) Natuve 325: 274); sorghum (Sorghum bicolov;
Cassas et al. (1993) Pvoc. Natl. Acad. Sci. USA 90: 11212);
sugar cane (Saccharum spp.; Bower and Birch (1992) Plant
J. 2: 409); tall fescue (Festuca avundinacea; Wang et al.
(1992) BioITechnology 10: 691); turfgrass (Agvostis palustvis; Zhong et al. (1993) Plant Cell Rep. 13: 1); and wheat
(Tviticum aestivum; Vasil et al. (1992) BioiTechnology 10:
667; Weeks et al. (1993) Plant Physiol. 102: 1077; Becker
et al. (1994) Plant J. 5: 299).
[0083] Once the construct of the present invention has
been introduced into the genome of a cell, the desired sense
or antisense sequence is expressed by the action of the
promoter. In the case of inducible or developmentally regulated promoters, expression will not be continuous but rather
will depend upon the presence of an inducing agent or
achievement of a developmental stage. In cases where a
tissue specific promoter has been used, expression will be
limited to the particular tissue.
[0084] Because, in one embodiment, the constructs of the
present invention lack a normal 3' UTR involved in nuclear
export of transcription products, the RNA produced is
retained within the nucleus. In another embodiment, the
construct includes a self-cleaving ribozyme. The self-cleaving nature of the ribozyme results in the production of free
sense or antisense RNA. The inability of the transcripts to be
exported from the nucleus, results in relatively high concentrations of the transcripts within the nucleus. As antisense RNA transcripts accumulate in the nucleus, they
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presumably hybridize to any complementary sense RNA
transcripts. Without being bound by theory, it is believed that
due to the high concentration of antisense transcripts within
the nucleus, it is more likely that senselantisense hybrids
will form than in the cytoplasm where antisense transcripts
are present at a lower concentration. It is also believed that
the formation of the hybrids results in an inability of the
sense RNA (mRNA) to be translated into the encoded
protein, but instead the hybrid RNA molecule is eventually
degraded within the nucleus. By preventing translation of
the mRNA into the encoded protein, the constructs of the
present invention result in the effective suppression of the
targeted gene or sequence. Furthermore, the presence of
senselantisense hybrids in the nucleus will presumably trigger a sequence-specific RNA degradation pathway, which
will further reduce the number of transcripts from the target
gene and increase the efficacy of gene down-regulation.
[0085] The mechanism by which localization of sense
transcripts within the nucleus results in suppression of gene
expression is unknown. Without being bound by theory, the
mechanism may be similar to that observed with co-suppression. The present invention, however, differs significantly from traditional co-suppression where co-suppression
is thought to result from interactions within the cytoplasm,
while the present invention relies upon the prevention of
nucleus to cytoplasm transport of RNA transcripts.
[0086] Once the constructs encompassed by the present
invention have been successfully introduced into the
genome of a plant, the plant can be replicated using traditional breeding techniques. For example, plants transformed
with the sense and/or antisense constructs can be "selfed" to
produce homozygous plants. Additionally, plants of the
present invention can be crossed to form hybrids containing
the sense and/or antisense constructs which can then be
selfed to form a homogeneous population. Thus, the present
invention encompasses not only plants containing the sense
and/or antisense constructs of the present invention, but also
seeds, hybrids and uniform populations produced from such
plants.
[0087] Likewise, once the constructs of the present invention have been introduced into the genome of an animal,
such a founder animal can be used to produce offspring by
any suitable method and the offspring then inbred to produce
a population homozygous for the construct.
EXAMPLES
[0088] The following examples are intended to provide
illustrations of the application of the present invention. The
following examples are not intended to completely define or
otherwise limit the scope of the invention.
Example 1
Vectors
[0089] Plasmid cloning was performed using standard
procedures (Sambrook et al. Molecular Cloning, 2nd ed.,
Cold Spring Harbor Laboratory Press, 1989). The binary
vector pPTN102 was assembled by ligating the Hind1111
EcoRI GUS cassette from pE7131-GUS (Mitsuhara et al.
(1996) Plant Cell. Physiol. 37:49) into pGPTV-hpt (Becker
et al. (1992) Plant Molec. Biol. 20:1195). The GUS reporter
gene was chosen to examine the role of 3'-end modification

of transcripts in plants. Four constructs were made with the
GUS reporter gene and a fifth construct without GUS served
as a negative control (FIG. 1).Plasmid pPTN102 was a
binary vector that contained GUS driven by the 35s promoter and ended with a CaMV 35s termination sequence for
nuclear export. The GUS gene was preceded by the TEV
leader and the W intron, and the GUS cassette was situated
between the right border and the hygromycin resistance
gene. The polyadenylation signal sequence in the plant
expression vector pRTL2 (Carrington and Freed (1990) J.
Vlrol. 64:1590) was replaced by a self-cleaving ribozyme
(RZ) (Liu and Carmichael(l994) Molec. Biotechnol. 2: 107)
from pBS-RZ-2 (a gift from Gordon Carmichael) to yield
pPTN106. The GUS open reading frame (ORF) was subcloned into pPTN106 to yield pPTN108 and pPTN109
which harbor ribozyme-terminated antisense GUS and sense
GUS, respectively. The vector pPTN107 is a derivative of
pRTL2 containing the antisense GUS cassette terminated by
a polyadenylation signal. The control and GUS cassettes
from pPTN106, pPTN107, pPTN108 and pPTN109 were
subcloned as Hind111 fragments into pPZP112 (Hajdukiewicz et al. (1994) Plant Mol. Biol. 25:989) to produce the
binary vectors pPTN110, pPTN111, pPTN112 and
pPTN113. Plasmid pPTNlllwas the same as pPTN102
except GUS was in the antisense orientation. Plasmid
pPTN112 possessed GUS in the antisense orientation, driven
by the CaMV 35s promoter and terminated with a cis-acting
ribozyme to promote generation of a free 3' end and to
promote nuclear retention, instead of the CaMV 35s termination sequence. For pPTN113, GUS was in the sense
orientation and terminated with a ribozyme. Plasmid
pPTNllO was a negative control which possessed a TEV
leader driven by the 3 5 s promoter and terminated with the
cis-cleaving ribozyme. Plasmids pPTN110, pPTN111,
pPTN112 and pPTN113 each had the GUS cassette situated
between the right border and the kanamycin resistance gene
instead of the hygromycin resistance gene used for
pPTN102. At least 3 individual transgenic tobaccos were
isolated harboring each construct.
[0090] The embryo-specific, FAD2-1 gene from soybean
was chosen to determine if the nuclear-localization strategy
could be employed for endogenous gene down-regulation.
Four binary constructs containing FAD2-1 were made (FIG.
2). The FAD2-1 ORF was isolated via PCR from genomic
DNA (soybean genotype A3237). PCR primers were
designed to published sequence (Heppard et al. (1996) Plant
Physiol. 110:311). The primers were Fad2-5 (5'-ttttttctagaactaggcatgggtctagc-3'; SEQ ID NO: 1) and Fad2-3 (5'-tttttggatccccatcaatacttgttc-3'; SEQ ID NO: 2) with an XbaI site on
the 5' primer and a BamHI site on the 3' primer. PCR
reactions included 200 ng of total genomic soybean DNA as
template, l x PCR buffer (20 mM Tris-HC1, pH=8.4,50 mM
KCl), 0.2 mM of each dNTP, 1.5 mM MgCl,, 10 ng of each
primer and 1 ml of Taq polymerase (Gibco Life Technologies Cat. # 18038-042). PCR conditions were: 1 cycle for 5
minutes at 94' C.; 2 cycles for 1 minute at 94' C., 1 minute
at 45" C., 2 minutes at 72' C.; 35 cycles for 1minute at 94'
C., 1 minute at 55' C., 2 minutes at 72' C.; and a 4" C.
holding temperature. The PCR product was digested with
BamHI and XbaI and subcloned into pBluescript KS+ to
yield pPTN156 and then sequenced. Four expression cassettes were assembled with the FAD2-1 ORF. All expression
cassettes were under the control of the common bean,
embryo-specific b-phaseolin promoter (PhP). FAD2-1 was
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subcloned downstream of the promoter in either sense or
antisense orientation. The antisense cassettes ended with a 3'
termination signal or a self-cleaving ribozyme. The respective cassettes were cloned into a binary vector which carried
a bar cassette under the control of the CaMV 35s promoter.
The resultant vectors, pPTN166, pPTN167, pPTN170 and
pPTN326, harbored the FAD2-1 cassettes in the following
orientations: PhP-antisense FAD2-1-RZ, PhP-sense FAD21-T35S, PhP-antisense FAD2-1-T35S and PhP-sense FAD21-RZ, respectively. Plasmid pPTN166 contained FAD2-1 in
antisense orientation driven by the embryo-specific, Phaseolin promoter and terminated with a ribozyme for nuclear
localization. Plasmid pPTN167 was a normal co-suppression construct. It contained FAD2-1 in sense orientation
driven by the Phaseolin promoter and ended with the CaMV
35s terminator for nuclear export. Plasmid pPTN170 was a
normal antisense construct. It was the same as pPTN167
except the FAD2-1 gene was in antisense orientation. Plasmid pPTN326 was the same as pPTN166 except FAD2-1
was in sense orientation. Each of these constructs possessed
a bar cassette for glufosinate selection.
[0091] The embryo-specific FatB and FAD2-1 genes were
employed to show that the nuclear-localized strategy could
be used to down-regulate multiple genes with a single
promoter. Two binary constructs, pPTN300 and pPTN303,
were made containing FatB and FAD2-1, both in sense
orientation and both driven simultaneously by the embryospecific, b-conglycinin promoter (FIG. 3).
[0092] The soybean FatB gene was kindly provided by
Tony Kinney of Dupont as clone pBS56 (A. J. Kinney
(1997) "Genetic Engineering of oilseeds for Desired Traits"
in Genetic Engineering vol. 19, pg. 149-166 (Setlow, J. K.
ed.) Plenum Press, N.Y.). An intermediate vector, FatIRZ
(PTN309) harboring the b-conglycinin promoter, FatB sense
ORF and ribozyme was made. The b-conglycinin promoter
and sense FatB ORF were PCR amplified from pBS56 using
a 5' primer TB-13, 5'-ATTACGAGCTCAAGCTTGATCCATGCCCTTC-3' (SEQ ID NO: 3), which contains SstI and
HindIII sites and is complementary to the upstream promoter sequence, and a 3' primer TB-14, 5'-AATCGGAATTCAAATC'ITAGGTGCTTTC-3' (SEQ ID NO: 4), which
contains an EcoRI site and is complementary to the 3'-end of
the FatB ORF including the stop codon. PCR reactions
included 100 ng of HindIII-digested pBS56, l x PCR buffer
(20 mM Tris-HC1, pH=8.4, 50 mM KCl), 0.2 mM of each
dNTP, 2 mM MgC1, and 0.1-1 mg of each primer in 100 ml
volume. PCR reactions were mixed, overlaid with 2 drops of
mineral oil and brought to 80' C. before adding 0.6 ml of
Taq polymerase. PCR reactions included 2 cycles at 94' C.
for 1 minute, 45" C. for 30 seconds, 72" C. for 2 minutes
followed by 7 cycles at 94' C. for 30 seconds, 55" C. for 30
seconds, 72" C. for 2.5 minutes and then 1 cycle at 72' C.
for 5 minutes. The PCR products were digested with SstII
EcoRI and subcloned into TB-RZ (pPTN304) to yield
pPTN309. TB-RZ (pPTN304) is a derivative of BS-RZ-2
(Liu and Carmichael (1994) Molec. Biotechnol. 2:107)
which was kindly provided by Gordon Carmichael. TB-RZ
was generated by HindIIIISalI digestion of BS-RZ-2, followed by mung bean nuclease treatment and self-ligation to
remove relevant restriction sites. DNA sequencing confirmed the removal of restriction sites.
[0093] Construction of pPTN300 required numerous intermediate vectors. Soybean FAD2-1 was PCR amplified using

a 5' primer TB-15, 5'-AATCGCTCGAGACTAGGCATGGGTCTAGC-3' (SEQ ID NO: 5), which contains a
XhoI site and the ATG start codon of FAD2-1, and a 3'
primer TB-16, 5'-AAATTGGTACCGAGCTCAAGCTTGAT'ITTGGTTTTAGGAA'ITAG-3'(SEQ ID NO: 6),
which contains KpnI, SstI and HindIII sites and is complementary to downstream sequence of the CaMV35S terminator. PCR reactions included 908 ng of HindIII-digested
pPTN167 which harbors the FAD2-1 ORF ended with the
CaMV35S terminator. PCR reactions contained l x buffer,
0.2 mM of each of the 4 dNTPs, 1.5 mM MgC1, and 1 mg
of each primer. PCR reactions were mixed, overlaid with 2
drops of mineral oil and brought to 80' C. before adding 0.5
ml of polymerase (containing 2.5 U of BRL Taq polymerase
and 0.025 U of Pfu polymerase (Stratagene #600153)). PCR
reactions included 2 cycles at 94' C. for 30 seconds, 40" C.
for 30 seconds, 72" C. for 7 minutes followed by 6 cycles at
94" C. for 30 seconds, 50" C. for 30 seconds, 72" C. for 7
minutes and then a 72" C. extension for 5 minutes. PCR
products were digested with XhoIKpnI and subcloned into
pPTN309 to generate FAT sense/RZ/FAD2-1 senselT35S in
KS+(pPTN312). The cassette from pPTN312 was digested
with SstI and subcloned into the binary vector pPTN130 to
generate pPTN300 (the pertinent sequence arrangement is
b-conglycinin promoter- FatB sense- RZ- FAD2-1 senseCaMV35S terminator).
[0094] Construction of pPTN303 also required numerous
intermediate vectors. FAD2-1 was PCR amplified using
FAD2-3 and FAD2-5 primers described earlier. PCR reactions included 100 ng of FAD2-1 template, l x buffer, 0.2
mM of each dNTP, 2 mM MgC1, and 0.1-1 mg of each
primer in 100 ml volume. Reactions were mixed, overlaid
with 2 drops mineral oil and brought to 80' C. before adding
0.8 ml of Taq polymerase. PCR reactions included 2 cycles
at 94" C. for 1 minute, 45" C. for 30 seconds, 72" C. for 2
minutes followed by 7 cycles at 94' C. for 30 seconds, 55"
C. for 30 seconds, 72" C. for 2.5 minutes and then a 72" C.
extension for 5 minutes. Amplification products were cut
with XbaIBamHI and subcloned into BS-RZ-2 to yield
FADBS-RZ-2 (pPTN305). Vector pPTN305 was then used
in another round of PCR to generate a sense FAD2-1/RZ
sequence with appropriate restriction sites. PCR reactions
included a 5' primer TB-15 (described above) and a 3' primer
5'-AAATTGGTACCGAGCTCGACGGTATCTB-17,
GATAAGCTT-3' (SEQ ID NO: 7), which contains KpnI,
SstI, ClaI and HindIII sites and has identity to the polycloning region of pBluescript. PCR reactions included 624 ng of
pPTN305 digested with SstI/XhoI, l x buffer, 0.2 mM of
each dNTP, 1.5 mM MgCl,, 1 mg of each primer in 100 ml
volume. Reactions were mixed, overlaid with 2 drops of
mineral oil and brought to 80' C. before adding 0.5 ml of
polymerase (containing 2.5 U of BRL Taq polymerase and
0.025 U of Pfu polymerase (Stratagene #600153)). PCR
reactions included 2 cycles at 94' C. for 30 seconds, 40" C.
for 30 seconds, 72" C. for 7 minutes followed by 6 cycles at
94" C. for 30 seconds, 50" C. for 30 seconds, 72" C. for 7
minutes and then a 72" C. extension for 5 minutes. PCR
products were digested with XhoIKpnI and sub-cloned into
pPTN309 to generate FAT senseBZIFAD2-1 sense1RZ in
KS+ (pPTN313). The cassette from pPTN313 was digested
with SstI and subcloned into the binary vector pPTN130 to
generate pPTN303 (the pertinent sequence arrangement is
b-conglycinin promoter- FatB sense- RZ- FAD2-1 senseRZ).
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[0095] Plasmids pPTN300 and pPTN303 both contain the
cis-cleaving ribozyme as a linker between the 2 genes as
well as a bar cassette for glufosinate selection. The only
difference between the 2 binaries was that plasmid pPTN300
was ended with a CaMV 35s terminator and plasmid
pPTN303 was terminated with a ribozyme.
Example 2
Tobacco and Soybean Transformations
[0096] Binary vectors were mobilized into Agrobacterium
tumefaciem strain C58C1 (Koncz and Schell (1986) Mol.
Gen. Genet. 204:383) by triparental matings (Ditta et al.
(1980) Proc. Natl. Acad. Sci. USA 77:7347). The Agrobacterium transconjugant carrying pPTN102 was selected on
LB plates supplemented with 50 mg/L rifampicin, 50 mgiL
gentamicin and 50 mgiL kanamycin. Agrobacterium
transconjugants carrying pPTN110, pPTN111, pPTN112
and pPTN113 were selected on LB supplemented with 50
mg/L rifampicin, 50 mg/L gentamicin and 75 mgiL chloramphenicol.
Agrobacterium
transconjugants
carrying
pPTN166, pPTN167, pPTN170, pPTN326, pPTN300 and
pPTN303 were selected on LB supplemented with 50 mgiL
rifampicin, 50 mgiL gentamicin, 100 mgiL streptomycin and
100 mg/L spectinomycin. Binary vectors in Agrobacterium
were confirmed by plasmid preps and restriction digestion
(Sambrook et al., Molecular Cloning, 2nd ed., Cold Spring
Harbor Laboratory Press, 1989).
[0097] Tobacco (cultivar Xanthi) transformations were
conducted via the leaf disc method described by Horsch et
al. (1985) Science 227:1229. Transformants were selected
on 10 mg/L hygromycin (pPTN102) or 150 mgbkanamycin
(pPTN110, pPTN111, pPTN112 or pPTN113). Soybean
transformations were conducted as described by Zhang et al.
(1999) Plant Cell, Tissue and Organ Culture 56:37) using
the cotyledonary-node transformation system (Hinchee et al.
(1988) BioITechnol. 6:915; Clemente et al. (2000) Crop Sci.
40:797). Transformants were selected on 5 mgiL glufosinate
during shoot initiation and 3 mg/L during shoot elongation
steps.
Example 3
RNA Isolation and Northern Blottinq
[0098] Comparison of the CaMV 35s terminator and the
cis-acting ribozyme with respect to sub-cellular transcript
localization was made using transgenic tobacco harboring
GUS constructs (FIG. 1). Evaluation of the foreign GUS
gene alleviated potential problems with gene silencing or
endogenous gene expression. To ascertain the sub-cellular
location of transcripts produced by the different clones, total
RNA and nuclei RNA were isolated from approximately 2
week old seedlings. A comparison of total RNA to nuclei
RNAwas made because RNAisolation from these compartments was much simpler and efficient compared to isolation
of cytoplasmic RNA from plants. Furthermore, the data
derived from these experiments was much simpler to standardize and interpret compared to isolation of cytoplasmic
RNA. This is because it is difficult to assess the amount of
RNA that is present from broken nuclei when using cytoplasmic RNA samples and isolation of cytoplasmic RNA
requires inconsistent and lengthy protocols.
[0099] Transgenic GUS tobacco seeds were sterilized by
suspending approximately 200-500 seeds in 1 ml of 50%

Clorox@, 0.02% Triton X-100 with constant agitation for 5
minutes at room temperature (RT). Samples were then spun
at 735x an for 5 seconds and the Clorox@ solution removed
with a pipette. Seeds were then resuspended in 1ml of sterile
deionized distilled water (ddH20) with constant agitation for
1 minute at room temperature followed by a brief 735x g
spin and removal of the water. Seeds were washed with
ddH20 a total of 4 times. Each sample was then suspended
in 1ml of ddH20 and transferred to a tube with 9 ml of 0.2%
Type A agar amended with 100 mg cefotaxime/L. This was
overlaid onto 150 mmxl5 mm petri plates containing selec~
salts and l x Fe-ethyltion medium: 0 . 5 Murashige-Skoog
ene diamine tetraacetic acid (EDTA) (Murashige and Skoog
(1962) Physiol. Plant 15:473), 1% sucrose, pH=5.7, 0.7%
Type A agar, l x Gamborg B5 vitamins (Gamborg et al.
(1968) Exp. Cell Res. 50:151) amended with 15 mg hygromycin1L andlor 100 mg kanamycin1L. Plates were wrapped
with Parafilm@ and incubated in a 24" C. growth chamber
with a 16 hour light18 hour dark photoperiod.
[0100] After a 2-3 week selection period, numerous whole
seedlings were harvested and weighed. Seedlings were then
subjected to RNA isolation. For intact RNA isolation, 100
mg of seedlings was processed with 0.75 ml Trizol LS (Life
Technologies, Inc., GibcoBRL, Rockville, MD) plus 0.1 ml
ddH-0
to the manufacturer's instructions. Two
'. accordinn
u
exceptions to the manufacturer's protocol included an additional chloroform extraction prior to isopropanol precipitation and RNA suspension in 100% formamide.
[0101] For total RNA and nuclei RNA isolation, seedlings
were ground in an ice-cold mortar with a glycerol extraction
buffer (10 mM HEPES, pH=8.0, 40% glycerol, 5 mM
MgCl,, 0.1 mM EDTA) at a ratio of 300 mg tissue per 1 ml
of ice-cold extraction buffer. For total RNA isolation, 0.25
ml of the homogenate was mixed with 0.75 ml of Trizol LS.
For nuclear RNA isolation, the remaining homogenate was
filtered through 1 layer of 33 mM nylon mesh (pre-washed
with ddH20 and autoclaved) into a centrifuge tube on ice.
The filtrate was spun in Eppendorf tubes at 1 , 3 1 0 ~g for
30-60 seconds. The supernatant was removed with a pipette.
The crude nuclei/organelle pellet was then resuspended in 1
ml of cold extraction buffer by gentle inversion. Samples
were next spun at 1 , 3 1 0 ~g for 30-60 seconds and the
supernatant was removed with a pipette. At this point, the
crude nuclei pellet was free from cell walls, cytoplasmic
components, and broken organelles. The resulting pellet(s)
was suspended in 0.25 ml of cold extraction buffer giving a
total volume of 0.3-0.35 ml. The crude nuclei suspension
was then mixed with 1.1 ml of Trizol LS. RNA extractions
were as above.
[0102] For Northern analysis 10 mg of RNA or 3 ml of
RNA marker (Life Technologies, Inc., GibcoBRL, Rockville, Md., cat # 15260-016) was combined with formamide,
1 ml of ethidium bromide (10 mg per ml), 0.45 ml formaldehyde, and 2 ml of l o x MESA buffer (0.4M MOPS,
pH=7.0, 0.1M NaAc, 10 mM EDTA) in 18 ml volume.
Samples were incubated at 75' C. for 5 minutes and then set
on ice. Next, 2 ml of lox stop dye (0.05% bromophenol
blue, 40% sucrose, 0.1M EDTA, 0.5% sodium dodecyl
sulfate (SDS)) was added. Samples were loaded onto a 1%
agarose, l x buffer ( l x MESA buffer, 0.3M formaldehyde)
gel and ran in l x buffer at 1.5-2.5 Vlcm for up to 6 hours.
Gels were washed by immersing 2 times in ddH20 and then
2 times in 2x SSC (Sambrook et al. Molecular Cloning, 2nd
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ed., Cold Spring Harbor Laboratory Press, 1989). Washes
were at room temperature with gentle agitation for 10
minutes each. RNA was transferred to positive nylon membranes (BioRad Laboratories, Hercules, Calif.) using 20x
SSC for 12-18 hours and subsequently fixed via UV irradiation. Filters were hybridized in 25 ml of 7% SDS, 0.5M
Na2HP0,, pH=7.2,1 mM EDTA, 1% bovine serum albumin
(BSA) amended with 10-15 ng of denatured probe. Probes
were labeled with [a-32P]dCTPusing the random priming kit
from Stratagene (La Jolla, Calif.). Hybridizations were incubated 14-20 hours at 65' C. Filters were washed under high
stringency including 2 washes of 0 . 2 ~SSC, 0.1% SDS at
65" C. for 10 minutes each. Filters were exposed to film with
intensifying screens at -80' C.

[0103] The results are shown in FIG. 4. Nuclei staining in
FIG. 4 shows that good nuclei were isolated. The large red
bodies are intact nuclei. The smaller, yellow-green bodies
are chloroplasts. These crude nuclei (organelle) fractions
were filtered and washed free of cytoplasmic components.
This contrasts with total nuclei RNA preps which contain
nuclei RNA, organelle RNA, and all cytoplasmic RNA
regardless of the RNA location within or among the plant
cells. Thus nuclei RNA samples have a much higher concentration of nuclei RNA than total RNA samples.
[0104] A TEV leader-GUS probe was used for Northern
analysis in FIG. 5. GUS expression for pPTN113 was very
low and this was observed for numerous individuals harboring pPTN113. The Northerns showed much higher levels
of total RNA than nuclear RNA for clones pPTN102 and
pPTN111. Subtraction of nuclear RNA from total RNA
implied that the majority of transcripts generated by these 2
clones resided outside of the nucleus. The opposite hybridization pattern was seen for clones pPTN110, pPTN112 and
pPTN113. These ribozyme-terminated constructs yielded
transcripts which appeared to accumulate exclusively in the
nucleus. The smaller molecular weight for the signal seen
for pPTNllO was exclusive to pPTNllO since it is the only
construct that expressed a TEV leader but no FAD2-1 ORF.
Example 4
In Situ Hybridization

[0105] All procedures were carried out at RT unless indicated otherwise. Root tips, taken from 2 week-old seedlings
grown on agar selection medium as described above, were
fixed in 4% paraformaldehyde in PBS (Sambrook et al.,
Molecular Cloning, 2nd ed., Cold Spring Harbor Laboratory
Press, 1989) for 2 hours. Roots were washed twice in PBS
for 10 minutes each, once in PBS amended with 1 mgiml
sodium borohydride for 10 minutes, and once in PBS plus
0.2% Triton X-100 for 15 minutes. Samples were incubated
in PBS containing 30% sucrose overnight at 4' C. Frozen
sections (8 mM in thickness) were collected on po1y-Llysine coated slides, air dried and stored at -20' C. overnight
before use. Slides containing sample sections were treated
with 0.2 N HC1 for 5 minutes, proteinase-K (5 uglml in TE
(10 mM Tris, 1 mM EDTA, pH=8.0)) for 10-15 minutes at
37" C., and 0.25% acetic anhydride plus 0.1M triethanolamine for 10 minutes. Samples were incubated in prehybridization buffer (5x SSC, l x Denhardt's solution, 1% SDS, 50
mglml denatured salmon sperm DNA, 50% formamide, 20
mM sodium phosphate, pH=6.6) for 2 hours at 50' C.
followed by an overnight hybridization at 50' C. in the same

buffer plus 10% dextran sulfate and GUS probe (1-2 mgiml).
GUS probes were antisense or sense-specific, DIG-labeled
RNA probes which were polymerized and then hydrolyzed
to less than 500 base pairs using the DIG labeling system
from Roche Molecular Biochemicals Inc. (Indianapolis,
Ind.). After washing with 2x SSC at 60' C. for 10 minutes
and 37" C. for 10 minutes, slides were treated with 0.2
mglml RNAase Ain 2x SSC, followed by a series of washes
~
at 37' C. for
with SSC. The final wash was with 0 . 2 SSC
30 minutes. Samples were rinsed once in TTBS (0.05%
Tween 20, l x TBS (20 mM Tris, 0.5M NaC1, pH=7.5)) and
then incubated with TTBS plus 5% BSA (Fraction-V) for 1
hour. Slides were then incubated in TTBS containing 1%
BSA and FITC-conjugated sheep anti-DIG antibodies (1:5
dilution, Roche Molecular Biochemicals, Inc.) for 2 hours.
After 2 washes with TTBS and 1wash with TBS (10 minutes
each), the slides were stained with 10 mglml propidium
iodide (DNA-staining) for 5 minutes, rinsed in TBS, and
mounted immediately for image collection. Images were
collected with a BioRad MRC1024ES confocal laser scanning microscope using a dual excitation (4881568 nm) and
dual emission (5201598 nm) program.

[0106] In situ hybridization using strand-specific GUS
probes and subcellular microscopy corroborated the Northern results. FIG. 6 shows hybridization results for transgenic
individuals harboring pPTNlll or pPTN112 which
expressed cytoplasm-localized GUS and nuclear-localized
GUS, respectively. The red channel showed nuclei staining
and the green channel showed in situ hybridization of
strand-specific probes. Comparing the green channel of
pPTNlll sense and antisense showed a much more intense,
disperse signal with the sense probe although some background was present with the antisense probe. The combined
channel shows yellowing of nuclei using the sense probe but
not the antisense probe indicating specific hybridization by
the sense probe. This was expected since some of the GUS
RNA should still be in the nuclei for pPTNlll transgenics
even though most of the RNA had been exported out of the
nucleus. Comparing the green channel of pPTN112 sense
and antisense showed staining of nuclei that was specific
only for the sense probe. There was some background
emanating from what appeared to be cell structure. Again,
the combined channel showed yellowing of nuclei for the
sense probe indicating specific binding by the sense probe
but not the antisense probe. Comparison of pPTNlll and
pPTN112 showed that the sense probe was disperse in the
pPTNlllsample and concentrated in the nucleus for
pPTN112.
Example 5
Fatty Acid Analysis

[0107] Seeds or seed chips for 4 to 8 TI, T2 or T3
generation of transgenic soybeans were used for fatty acid
analysis. Fatty acid analysis was performed using gas chromatography according to the procedure of Butte et al.
((1982) Analytical Lett., 15(A10):841-850).
[0108] Transgenic soybeans were selected with glufosinate, and the presence of a T-DNA was confirmed by
Southern analysis (data not shown). Fatty acid analysis was
performed on up to 8 seed chips from each T1 transgenic
(Table 1). Ahigh oleic acid phenotype was observed for 3 of
4 transgenic soybeans harboring nuclear-localized antisense
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FAD2-1 (pPTN166). Transgenics 1-3, 1-5 and 1-6 yielded
an average of 63.0+6.2% oleic acid compared to 13.7% for
wild-type. A high oleic acid phenotype was observed for 2
of 9 transgenic soybeans harboring cytoplasm-localized
antisense FAD2-1 (pPTN170). Transgenics 3-1 and 3-2
yielded an average of 83.0+1.1% oleic acid compared to
13.7% for wild-type. Two of the eight soybean transformants
carrying the sense nuclear-localized FAD2-1 (pPTN326)
displayed an elevated oleic acid phenotype as shown in
Table 1. Soybean transformants 6-1, and 6-2 possessed oleic
acid levels of 77.2% and 77.3% respectively. As expected,
the high oleate acid phenotype came primarily at the
expense of polyunsaturates (18:2+18:3), although there was
also a noticeable decrease in saturates (16:0+18:0). There
were no high oleate transgenics harboring the normal cosuppression construct pPTN167.

[0109] Transgenic soybeans with dual gene constructs
were selected with glufosinate and the presence of a T-DNA
was confirmed by Southern analysis (data not shown). Fatty
acid analysis was performed on up to 8 seed chips from each
T1 transgenic (Table 2). A high oleate acid phenotype was
observed for 6 of 15 transgenic soybeans harboring
pPTN300. Five of these transgenics 4-3, 4-6, 4-14 and 4-15
yielded an average of 66.2+11.0% oleic acid compared to
13.7% for wild-type. The decrease in polyunsaturates
(18:2+18:3) indicated down-regulation of the FAD2-1
desaturase. Transgenic 4-2 was the only pPTN300 transgenic with a highly significant decrease in saturated fatty
acids (16:0+18:0) in addition to a large increase in oleic acid.
This transgenic had 5.7% saturates compared to 15.8% for
wild-type which indicated that the FatB thioesterase gene
had been down-regulated, while the increase in oleic acid
and decrease in polyunsaturates was the result of downregulated FAD2-1. A high oleate phenotype was observed
for 5 of 27 transgenic soybeans harboring pPTN303. Four of
the five pPTN303 transgenics (5-3, 5-5, 5-10 and 5-24)
yielded an average of 89.2%+1.6% compared to 13.7% for
wild-type. The great decrease in polyunsaturates and
increase in oleic acid indicated strong FAD2-1 down-regulation. Importantly, the saturated fatty acid composition
(16:0+18:0) of these four pPTN303 transgenics was
decreased to an average of 5.2%+0.3% compared to 15.8%
for wild-type indicating FatB thioesterase down-regulation
in all 3 transnenics. Thus. the ribozvme-terminated
pPTN303 construct produced a very dramatic phenotype and
was more effective for down regulating multiple genes at
one time compared to pPTN300.

may function, the inventors do not intend to be bound by
those conclusions and functions, but put them forth only as
possible explanations.

[0112] It is to be further understood that the specific
embodiments of the present invention as set forth are not
intended as being exhaustive or limiting of the invention,
and that many alternatives, modifications, and variations
will be apparent to those of ordinary skill in the art in light
of the foregoing examples and detailed description. Accordingly, this invention is intended to embrace all such alternatives, modifications, and variations that fall within the
spirit and scope of the following claims.
TABLE 1
Fatty Acid Profiles of Transgenic Soybeans
Harboring Vectors PTN166, PTN167 or PTN170
No.

Event

Vector

16:O

18:O

18:l

18:2

18:3

-

[0113]
TABLE 2

Conclusion

[0110] In light of the detailed description of the invention
and the examples presented above, it can be appreciated that
the several aspects of the invention are achieved.
[Olll] It is to be understood that the present invention has
been described in detail by way of illustration and example
in order to acquaint others skilled in the art with the
invention, its principles, and its practical application. Particular formulations and processes of the present invention
are not limited to the descriptions of the specific embodiments presented, but rather the descriptions and examples
should be viewed in terms of the claims that follow and their
equivalents. While some of the examples and descriptions
above include some conclusions about the way the invention

Fatty Acid Profiles of Transgenic Soybeans
Harboring Vectors PTN300 or PTN303
No.

Event

Vector

16:O

18:O

18:l

18:2

18:3
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TABLE 2-continued

TABLE 2-continued

Fatty Acid Profiles of Transgenic Soybeans
Harboring Vectors PTN300 or PTN303

Fatty Acid Profiles of Transgenic Soybeans
Harboring Vectors PTN300 or PTN303

No.

Event

Vector

16:O

18:O

18:l

18:2

18:3
No.

SEQUENCE L I S T I N G

< 1 6 0 > NUMBER O F S E Q I D NOS:
<210>
<211>
<212>
<213>
<2 2 0 >
<221>
<222>
<223>

7

S E Q I D NO 1
LENGTH: 2 9
T Y P E : DNA
ORGANISM: A r t i f i c i a l S e q u e n c e
FEATURE :
NAME/KEY: m i s c - f e a t u r e
LOCATION: ( 1 ) . . ( 2 9 )
OTHER INFORMATION: p r i m e r

< 4 0 0 > SEQUENCE:

I

t t t t t t c t a g aactaggcat gggtctagc

<210>
<211>
<212>
<213>
<2 2 0 >
<221>
<222>
<223>

S E Q I D NO 2
LENGTH: 2 7
T Y P E : DNA
ORGANISM: A r t i f i c i a l S e q u e n c e
FEATURE :
NAME/KEY: m i s c - f e a t u r e
LOCATION: ( 1 ) . . ( 2 7 )
OTHER INFORMATION: p r i m e r

< 4 0 0 > SEQUENCE:

2

t t t t t g g a t c cccatcaata c t t g t t c

<210>
<211>
<212>
<213>
<2 2 0 >
<221>
<222>
<223>

S E Q I D NO 3
LENGTH: 3 1
T Y P E : DNA
ORGANISM: A r t i f i c i a l S e q u e n c e
FEATURE :
NAME/KEY: m i s c - f e a t u r e
LOCATION: ( 1 ) . . ( 3 1 )
OTHER INFORMATION: p r i m e r

< 4 0 0 > SEQUENCE:

3

attacgagct caagcttgat ccatgccctt c

Event

Vector

16:O

18:O

18:l

18:2

18:3
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<210>
<211>
<212>
<213>
<220>
<221>
<222>
<223>

S E Q I D NO 4
LENGTH: 2 8
T Y P E : DNA
ORGANISM: A r t i f i c i a l S e q u e n c e
FEATURE:
NAME/KEY: m i s c - f e a t u r e
LOCATION: ( 1 ) . . ( 2 8 )
OTHER INFORMATION: p r i m e r

< 4 0 0 > SEQUENCE:

4

aatcggaatt caaatcttag gtgctttc

<210>
<211>
<212>
<213>
<220>
<221>
<222>
<223>

S E Q I D NO 5
LENGTH: 2 9
T Y P E : DNA
ORGANISM: A r t i f i c i a l S e q u e n c e
FEATURE:
NAME/KEY: m i s c - f e a t u r e
LOCATION: ( 1 ) . . ( 2 9 )
OTHER INFORMATION: p r i m e r

< 4 0 0 > SEQUENCE: 5
aatcgctcga gactaggcat gggtctagc

<210>
<211>
<212>
<213>
<220>
<221>
<222>
<223>

S E Q I D NO 6
LENGTH: 4 4
T Y P E : DNA
ORGANISM: A r t i f i c i a l S e q u e n c e
FEATURE:
NAME/KEY: m i s c - f e a t u r e
LOCATION: ( 1 ) . . ( 4 4 )
OTHER INFORMATION: p r i m e r

< 4 0 0 > SEQUENCE:

6

aaattggtac cgagctcaag cttgattttg gttttaggaa t t a g

<210>
<211>
<212>
<213>
<220>
<221>
<222>
<223>

S E Q I D NO 7
LENGTH: 3 5
T Y P E : DNA
ORGANISM: A r t i f i c i a l S e q u e n c e
FEATURE:
NAME/KEY: m i s c - f e a t u r e
LOCATION: ( 1 ) . . ( 3 5 )
OTHER INFORMATION: p r i m e r

< 4 0 0 > SEQUENCE:

7

aaattggtac cgagctcgac ggtatcgata agctt

What is claimed is:
1.A method for suppressing gene expression in a eukaryotic cell comprising, transforming said cell with a recombinant construct comprising, a promoter functional in said
cell operatively linked to a sense nucleotide sequence of a
gene to be suppressed, wherein nucleus-to-cytoplasm transport of transcription products of said construct is inhibited.
2. The method of claim 1, wherein said inhibition of
nucleus-to-cytoplasm transport is due to a lack of a normal
3' UTR.
3. The method of claim 1, wherein said inhibition of
nucleus-to-cytoplasm transport is due to a lack of a 3'
terminal sequence.

4. The method of claim 1, wherein said construct further
comprises at least one self cleaving ribozyme.
5. The method of claim 1, wherein said promoter is
selected from the group consisting of a constitutive promoter, an inducible promoter, a tissue specific promoter, and
a developmentally regulated promoter.
6. The method of claim 1, wherein said construct further
comprises at least one additional sense nucleotide sequence
of at least one additional gene operatively linked to said
promoter.
7. A method for suppressing gene expression in a eukaryotic cell comprising, transforming said cell with a recombinant construct comprising, a promoter functional in said
cell operatively linked to a plurality of antisense nucleotide
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sequences of a gene or genes to be suppressed, wherein
nucleus-to-cytoplasm transport of transcription products of
said construct is inhibited.
8. The method of claim 7, wherein said inhibition of
nucleus-to-cytoplasm transport is due to a lack of a normal
3' UTR.
9. The method of claim 7, wherein said inhibition of
nucleus-to-cytoplasm transport is due to a lack of a 3'
terminal sequence.
10. The method of claim 7, wherein said construct further
comprises at least one self cleaving ribozyme.
11. The method of claim 7, wherein said promoter is
selected from the group consisting of a constitutive promoter, an inducible promoter, a tissue specific promoter, and
a developmentally regulated promoter.
12. A method for suppressing expression of a gene in a
plant cell, comprising transforming said plant cell with a
recombinant construct comprising, a promoter functional in
said plant cell, and an antisense nucleotide sequence for the
gene to be suppressed, wherein nucleus-to-cytoplasm transport of transcription products of said construct is inhibited.
13. The method of claim 12, wherein said inhibition of
nucleus-to-cytoplasm transport is due to a lack of a normal
3' UTR.
14. The method of claim 12, wherein said construct
further comprises at least one self cleaving ribozyme.
15. The method of claim 12, wherein said promoter is
selected from the group consisting of a constitutive promoter, an inducible promoter, a tissue specific promoter, and
a developmentally regulated promoter.
16. A recombinant vector comprising, a promoter functional in a eukaryotic cell operatively linked to a nucleotide
sequence selected from the group consisting of:
a) at least one sense nucleotide sequence of at least one
gene to be suppressed,
b) a plurality of antisense nucleotide sequences of at least
one gene to be suppressed, and
c) at least one antisense nucleotide sequence for at least
one gene to be suppressed;
wherein nucleus-to-cytoplasm transport of transcription
products of said at least one nucleotide sequence is
inhibited.
17. The recombinant vector of claim 16, wherein said
inhibition of nucleus-to-cytoplasm transport is due to a lack
of a normal 3' UTR.
18. The recombinant vector of claim 16, wherein said
construct further comprises at least one self cleaving
ribozyme.
19. The recombinant vector of claim 16, wherein said
promoter is selected from the group consisting of a constitutive promoter, an inducible promoter, a tissue specific
promoter, and a developmentally regulated promoter.
20. A host cell comprising the recombinant vector of
claim 16.
21. A eukaryotic cell whose genome includes a recombinant construct comprising, a promoter functional in said
eukaryotic cell operatively linked to at least one sense

nucleotide sequence of at least one gene to be suppressed,
wherein nucleus-to-cytoplasm transport of transcription
products of said construct is inhibited.
22. The eukaryotic cell of claim 21, wherein said inhibition of nucleus-to-cytoplasm transport is due to a lack of a
3' terminal sequence.
23. The eukaryotic cell of claim 21, wherein said inhibition of nucleus-to-cytoplasm transport is due to a lack of a
normal 3' UTR.
24. The eukaryotic cell of claim 21, wherein said construct further comprises at least one self cleaving ribozyme.
25. The eukaryotic cell of claim 21, wherein said promoter is selected from the group consisting of a constitutive
promoter, an inducible promoter, a tissue specific promoter,
and a developmentally regulated promoter.
26. A plant comprising at least one cell of claim 21.
27. A eukaryotic cell whose genome includes a recombinant construct comprising, a promoter functional in said
eukaryotic cell operatively linked to a plurality of antisense
nucleotide sequences of at least one gene to be suppressed,
wherein nucleus-to-cytoplasm transport of transcription
products of said construct is inhibited.
28. The eukaryotic cell of claim 27, wherein said inhibition of nucleus-to-cytoplasm transport is due to a lack of a
normal 3' UTR.
29. The eukaryotic cell of claim 27, wherein said inhibition of nucleus-to-cytoplasm transport is due to a lack of a
3' terminal sequence.
30. The eukaryotic cell of claim 27, wherein said construct further comprises at least one self cleaving ribozyme.
31. The eukaryotic cell of claim 27, wherein said promoter is selected from the group consisting of a constitutive
promoter, an inducible promoter, a tissue specific promoter,
and a developmentally regulated promoter.
32. A plant comprising at least one cell of claim 27.
33. plant cell-whose genome includes a recombinant
construct comprising, a promoter functional in said plant
cell operatively linked to at least one antisense sequence for
at least one gene to be suppressed; wherein nucleus-tocytoplasm transport of transcription products of said construct is inhibited.
34. The plant cell of claim 33, wherein said inhibition of
nucleus-to-cytoplasm transport is due to a lack of a normal
3' UTR.
35. The plant cell of claim 33, wherein said inhibition of
nucleus-to-cytoplasm transport is due to a lack of a 3'
terminal sequence.
36. The plant cell of claim 33, wherein said construct
further comprises at least one self cleaving ribozyme.
37. The plant cell of claim 33, wherein said promoter is
selected from the group consisting of a constitutive promoter, an inducible promoter, a tissue specific promoter, and
a developmentally regulated promoter.
38. A plant comprising at least one cell of claim 33.
39. A seed from the plant of claim 38.
40. The progeny of the plant of claim 38.

